OSCR Stock Analysis: Buy, Sell, or Hold?
OSCR - Oscar Health, Inc.
$31.40
0.33 (1.06%)
▲
5d:
+1.91%
30d:
+11.11%
90d:
+105.36%
WAIT
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 05, 2026
20d
Smart Money Distribution
None View Scanner →
Strength: 9.8/10
Get Alerted When OSCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OSCR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OSCR shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.33
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$25.04
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSCR is currently trading at $31.40, which is considered extended relative to its 30-day fair value range of $28.20 to $31.15. From a valuation perspective, the stock is trading at a premium (Forward PE: 20.9) compared to its historical average (13.9). At these levels, the market is pricing in 14.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OSCR is in a strong uptrend. The price is approaching resistance at $28.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $23.80. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSCR is in a strong uptrend. The price is approaching resistance at $28.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $23.80. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$28.20 -
$31.15
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
41.4%
Protect Your Profits
Holding OSCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 23.4% above Wall St target ($23.80)
- NEUTRAL: PE elevated vs history but 14.4% growth expectation is conservative given 126% recent growth
Trading Range Analysis
30-Day Trading Range
$28.20 -
$31.15
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.09
Resistance Level
$28.16
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.86
Wall Street Target
$23.80
(-23.4%)
Revenue Growth (YoY)
52.6%
Earnings Growth (YoY)
125.6%
Profit Margin
-0.3%
Valuation Premium vs History
+14.4% premium
PE vs Historical
20.9 vs 13.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+14.4%
(market-implied from PE analysis)
1-Year Target
$35.54
(+14%)
2-Year Target
$40.66
(+31%)
3-Year Target
$46.52
(+50%)
3-Yr Target (if PE normalizes)
(PE: 21→14)
PE COMPRESSION
$31.00
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 40.1%)
$89.25
(+187%)
Base:
(SPY PE: 20.9, Growth: 40.1%)
$85.46
(+175%)
Bear:
(PE: 13.9, Growth: 40.1%)
$56.96
(+83%)
Share & Embed Analysis
Last updated: July 15, 2026 12:08 PM ET
Data refreshes hourly during market hours. Next update: 1:08 PM
Data refreshes hourly during market hours. Next update: 1:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSCR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Mark T Bertolini
BUY
1000000 shares
2026-04-06
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$109 | 65 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$420 | 54 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 62 BUY |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$431 | 63 BUY |
|
HUM
Humana Inc |
HOLD
26 analysts |
$315 | 58 HOLD |
Advanced OSCR Option Strategies
Professional options setups generated by AI based on today's OSCR price and gamma walls.
